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RedoxThe mitochondrial ATP-sensitive potassium channel (mKATP) is important in the protective mechanism of
ischemic preconditioning (IPC). The channel is reportedly sensitive to reactive oxygen and nitrogen species,
and the aim of this study was to compare such species in parallel, to build a more comprehensive picture of
mKATP regulation. mKATP activity was measured by both osmotic swelling and Tl+ ﬂux assays, in isolated rat
heart mitochondria. An isolated adult rat cardiomyocyte model of ischemia–reperfusion (IR) injury was also
used to determine the role of mKATP in cardioprotection by nitroxyl. Key ﬁndings were as follows: (i) mKATP
was activated by O2•− and H2O2 but not other peroxides. (ii) mKATP was inhibited by NADPH. (iii) mKATP was
activated by S-nitrosothiols, nitroxyl, and nitrolinoleate. The latter two species also inhibited mitochondrial
complex II. (iv) Nitroxyl protected cardiomyocytes against IR injury in an mKATP-dependent manner. Overall,
these results suggest that the mKATP channel is activated by speciﬁc reactive oxygen and nitrogen species, and
inhibited by NADPH. The redox modulation of mKATP may be an underlying mechanism for its regulation in
the context of IPC. This article is part of a Special Issue entitled: Mitochondria and Cardioprotection.hondria and Cardioprotection.
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The past 25 years has witnessed much investigation into the
phenomenon of ischemic preconditioning (IPC), in which short non-
lethal periods of ischemia and reperfusion (IR) can elicit protection
against prolonged ischemia–reperfusion (IR) injury [1]. Despite this
effort, the mechanism by which IPC protects organs such as the heart
and brain from IR injury is still debated.
One proposed mechanism of IPC-induced cardioprotection is the
opening of a mitochondrial ATP-sensitive potassium channel (mKATP),
which elicits mild swelling of the mitochondrial matrix. This in turn is
thought to impact on mitochondrial Ca2+ loading, reactive oxygen
species (ROS) generation, metabolic efﬁciency, and assembly of the
permeability transition pore [2], and these downstream events bring
about protection via unclear mechanisms. Although the molecular
identity of the mKATP channel remains unknown, several pharmaco-
logic mKATP modulators mimic IPC, and many IPC signaling pathways
are thought to converge on mKATP as an end effector [3].
Mitochondria are a quantitatively signiﬁcant source of ROS, which
contribute to tissue damage during ischemia, but are alsomediators of
IPC signaling [4]. Accumulating evidence suggests that redox signalingpathways play an important role in IPC [5–9], and can promote mKATP
activation [10–15]. The primary ROS generated by mitochondria is
superoxide (O2•−) [16,17], while hydrogen peroxide (H2O2) or lipid
peroxides can be formed secondarily [17]. Both O2•− and H2O2 are
thought to activate mKATP [13,18–20], although conﬂicting reports
exist regarding O2•− [18,20]. The effect of other peroxides on mKATP is
not known. Furthermore, it is apparent that some but not all types of
antioxidants can inhibit IPC and mKATP activity [6,13], warranting
further investigation. Table 1 summarizes the disparate results to date
regarding redox regulation of the mKATP channel.
Nitric oxide (NO•) is also implicated in IPC, and elicits a large
variety of cardioprotective effects [21]. NO• has been detected in
isolated mitochondrial preparations [22], and can secondarily
generate many reactive nitrogen species (RNS) [23–25], which can
serve either damaging or beneﬁcial signaling roles [17,21,25,26].
mKATP is a potential target for such RNS, and while high doses
(10 mM) of an S-nitrosothiol have been shown to activate the
channel in intact mitochondria [20], evidence for more subtle
physiologically relevant effects of NO• has mostly relied on indirect
measures of channel activity [27] or study of the channel removed
from its mitochondrial environment [28]. Thus, it is not clear
whether the levels of NO• that would be experienced inside
mitochondria are capable of modulating mKATP activity.
The one electron reduction product of NO•, nitroxyl (HNO) may
also modulate the mKATP channel. Nitroxyl is protective in IR injury
[29], and while it shares some signaling pathways with NO•, it also
possesses distinct biochemistry from NO•, such as a direct interaction
Table 1
Previous studies on the effects of oxidants, reactive nitrogen species, antioxidants and reducing agents on mKATP channel activity.
Reagent Conc. Effects Experimental conditions References
Ascorbate 1 mM No effect Isolated mitochondria [12]
DTE 10 mM Inhibits glyburide binding Submitochondrial particles [46]
DTNB 500 μM Inhibits glyburide binding Submitochondrial particles [46]
DTT 100 μM Inhibits activation by DZX Isolated mitochondria [12,13]
1 mM Activates run-down channels Reconstituted channels [66]
Loss in selectivity
10 mM Inhibits glyburide binding Submitochondrial particles [46]
Mersalyl 100 μM Inhibits glyburide binding Submitochondrial particles [46]
MPG 200 μM Inhibits activation by DZX Isolated mitochondria [12,13,31]
NAC 4 mM Inhibits activation by DZX Isolated mitochondria [12,13]
NEM 2 mM Inhibits activation by O2•− Reconstituted channels [18]
Inhibits glyburide binding Submitochondrial particles [46]
60 nmol/mg Decreases selectivity Isolated mitochondria [67]
Thimerosal 500 μM Inhibits glyburide binding Submitochondrial particles [46]
X/XO 0.038 U/mL Activates Reconstituted channels [18]
6 mU/mL No Effect Isolated mitochondria [20]
H2O2 1 μM Activates Isolated mitochondria [13]
1 μM Activates Isolated mitochondria [19]
6 mU/mL X/XO+30 U SOD Activates Isolated mitochondria [20]
SNAP 10 mM Activates Isolated mitochondria [20]
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mitochondrial complex II in a manner sensitive to glutathione and
independent of S-nitrosation [30]. mKATP activity is exquisitely
sensitive to complex II modulation [31,32], and herein we explored
the concept that nitroxylmay regulatemKATP via effects on complex II.
Despite a collection of studies to date examining the effect of single
redox agents on mKATP, often at high doses, a comparative study
across a wide range of doses is lacking. In addition, unique chemical
properties of certain NO• derived species have precluded their use to
date in studying mKATP. The current study aimed to address such
issues, and the collective results suggest that mitochondrial redox
state is an important regulator of mKATP channel activity, mitochon-
drial function, and cardioprotection in the context of IPC.
2. Materials and methods
Full experimental details are in the online supplement.
2.1. Animals, chemicals and supplies
Male Sprague–Dawley rats, 200–300 g, were purchased from
Harlan (Indianapolis, IN) or bred at the Biotério do Conjunto das
Químicas (Universidade de São Paulo) housed on a 12 h light/dark cycle
with food and water available ad libitum. All procedures were
performed in accordance with the US National Institutes of Health
“Guide for the care and use of laboratory animals” and the Colégio
Brasileiro de Experimentação Animal, and were approved by the
appropriate university animal ethics committees. Linoleic peroxide
was a kind gift from Sayuri Miyamoto (São Paulo) and stored under
argon in methanol [33]. Nitro-linoleate was synthesized and analyzed
as previously described [34]. All other reagents used were analytical
grade or higher, obtained from Sigma (St. Louis MO) or EMD
(Gibbstown NJ).
2.2. Mitochondrial isolation, Cx-II, and mKATP assays
Heart mitochondria were rapidly isolated as previously described
[31,35]. Cx-II activity was measured as previously described [31,32].
mKATP activity was measured by osmotic swelling as previously
described [32,36]. All channel modulating agents (reactive oxygen
and nitrogen species, antioxidants, etc.) were present in the assay
buffer prior to mitochondrial addition. The nature of the mKATP
osmotic swelling assay, requiring mitochondrial addition last of all,precludes its use to study highly reactive species such as HNO [37]. In
such cases a ﬂuorescence-based Tl+ ﬂux assay for mKATP activity [38]
was used, permitting incubation of mitochondria prior to assay
initiation by Tl+ addition.2.3. Cardiomyocyte model of IR injury
Adult rat ventricular myocytes were isolated, and a model of
simulated IR (SIR) injury was as previously described [32]. Cells were
incubated in anoxic glucose-free Krebs Henseleit (KH) buffer at pH 6.5
for 30 min, followed by reoxygenation in glucose-replete KH at pH 7.4.
Where indicated, compounds were present 20 min prior to the onset
of simulated ischemia. At the end of all protocols, viability was
determined by Trypan blue exclusion.2.4. Statistics
All experiments were performed on at least 3 independent
mitochondrial or cell preparations, and results are presented as
mean±SEM. Statistical signiﬁcance between groups was determined
by ANOVA.3. Results and discussion
3.1. mKATP is activated by some but not all peroxides
While the ability of ROS to modulate mKATP activity has been
reported [13,18–20], the differential action of various classes of ROS is
less well understood. In particular, ROS such as H2O2 may initiate
chemistry that generates secondary peroxides such as lipid hydro-
peroxides (LOOH) [17]. We therefore hypothesized that peroxides
may modulate mKATP activity. In Fig. 1A, the effects of H2O2, t-butyl
hydroperoxide (t-BuOOH), and linoleic hydroperoxide (LOOH) on
mKATP were tested. Interestingly, while H2O2 robustly opened the
channel at 1 μM, higher concentrations of t-BuOOH and LOOH did not.
The differential hydrophobicity of t-BuOOH, LOOH, and H2O2 suggests
that the peroxide sensor of mKATP may be in a hydrophilic region of
themolecule. Alternatively, it has been suggested that H2O2 activation
of the mKATP may occur via a PKCε dependent mechanism [20],
although the location of the kinase in this particular mitochondrial
preparation is unknown.
Fig. 1. Selective mKATP activation by ROS: mKATP activity was measured by osmotic swelling as detailed in Materials and methods. Controls (Na+ based media) are in Fig. S1.
(A): mKATP is activated by H2O2 but not by t-BuOOH or LOOH. Diazoxide (DZX) opening of mKATP was used as a positive control. (B): mKATP activation by O2•− generated by the X/XO
system. Glyburide (Glyb) and 5-hydroxydecanoate (5-HD) are mKATP antagonists. (C): Dose response of mKATP activation by X/XO in K+ (black circles) or Na+ (gray triangles) based
media. *pb0.05 vs. ATP alone. #pb0.05 vs. ATP+H2O2 or X/XO. Experimental conditions are listed below the X axis.
Fig. 2. Inhibition of DZX-activated mKATP by reductants: mKATP activity was measured
by osmotic swelling as detailed in Materials and methods. Data are shown for the
baseline condition (open bars) or maximal swelling in the presence of both ATP and
DZX (ﬁlled bars). Reductants were present in the media before mitochondrial addition,
at the concentrations indicated. *pb0.05 vs. the appropriate control (bar marked Ctrl.)
in the absence of reductant.
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Activation of mKATP by O2•− has been reported previously [18], but
at relatively high doses. It is unclear whether the amounts of O2•−
made by mitochondria are capable of modulating mKATP activity. To
investigate this, a xanthine/xanthine oxidase (X/XO) systemwas used
to modulate ROS ﬂux. Fig. 1B and C shows that XO levels as low as
1.4 U/mL (approximating to a O2•− ﬂux of 1.2 μM/min) activated the
channel. Reported maximal rates of O2•− generation by heart
mitochondria range from 30 nM/min to 1 μM/min [39,40]. Thus, it is
unlikely that mitochondrial O2•− generation under normal conditions
approaches levels required for mKATP channel activation. This ﬁnding
suggests that the channel would only be activated in situ with ROS
originated from non-mitochondrial sources or conditions that
increase ROS production such as pre- and post-conditioning. Also
under conditions of reverse electron ﬂow, O2•− in the mitochondrial
microenvironment may reach levels capable of activating the channel
[13]. No effect of H2O2 or X/XO on mitochondrial swelling was
observed in Na+ based media (supplemental Fig. 1).
3.3. mKATP is inhibited by some but not all reductants/antioxidants
While IPC is inhibited by both thiol antioxidants and catalase
(suggesting a role for H2O2 [12]), cardioprotection by mKATP agonists
such as diazoxide is prevented only by thiol antioxidants [13],
suggesting that antioxidant-sensitive proteins distinct from mKATP
may be important in IPC (e.g. SERCA, [41]). Thus, a detailed
understanding of the selective regulation of mKATP by reductants is
a key step toward understanding its role in IPC.
The effect of several reducing agents on mKATP activity was tested
under baseline conditions and conditions of maximal channel opening
(presence of ATP and diazoxide). Fig. 2 shows that while most
reducing agents had amild inhibitory effect onmKATP activity, NADPH
was a strong inhibitor, almost completely preventing channel activity.
Compiling these data with those from our previous study [13],
supplemental Fig. 2 shows the ability of reductants to inhibit mKATP
channel activity correlated with redox potential (r2=0.73). A notable
outlier to this correlation was NADPH (inclusion of NADPH in the
linear regression ﬁt lowers r2 to 0.43). The underlying mechanism for
a difference in the effect of NADH vs. NADPH, despite their identical
redox potentials, is elusive at this stage. Interestingly, while both
surface KATP channels [42–45] and themKATP [12,13,18,46,47] do have
redox active thiols, NADPH does not directly reduce thiols, suggesting
that its direct redox activity is not the mechanism of channel
regulation.Nevertheless, NADPH does play an important role in overall
mitochondrial redox status; transhydrogenases reduce mitochondrial
NADP+ using electrons from NADH and the electrochemical proton
gradient as an energy source [48]. The resulting NADPH is used as an
electron source for thiol peroxidase removal systems, including
glutathione and thioredoxin peroxidase/reductase [17]. Thus, the
ﬁnding that NADPH can regulate mKATP activity suggests that this
channel may play a role in sensing both energy metabolism and redox
status [13,49].
Notably, surface KATP channel activity has been shown to be
sensitive to pyridine nucleotides [50], possibly at the same site as
adenine nucleotides modulate channel activity. Furthermore, insulin
secretion in pancreatic β cells, which occurs secondarily to KATP
closure, correlates with NADPH/NADP+ ratios [51]. Thus, a direct
modulation of the mKATP channel by NADPH binding may occur.
Another possibility might be that NADPH competes with DZX for a
binding site on themKATP channel. However, we consider this unlikely
since NADPH was also able to inhibit channel opening by the
structurally unrelated opener atpenin A5 [32] (supplemental Fig. 3).
Fig. 3. mKATP activation by S-nitrosothiols and mitochondrial-associated NOS: mKATP
activity was measured by osmotic swelling as detailed in Materials and methods. Controls
(Na+basedmedia) are inFig. S2. (A):mKATPwas activated by S-nitrosoacetylpenacillamine
(SNAP) and S-nitrosoglutathione (GSNO), at the indicated doses. (B): Dose response of
mKATP activation by SNAP in K+ (black circles) or Na+ (gray triangles) based media.
*pb0.05 vs. ATP alone. #pb0.05 vs. ATP plus SNAP. (C): mKATP activation by NOS
modulators. L- or D-Arginine, L-nitroarginine methyl ester (NAME), Glyb and 5-HD were
presentat theconcentrations indicated. *pb0.05 vs. *pb0.05vs. ATPalone. #pb0.05 vs. ATP
plus L-arginine.
Fig. 4. LA-NO2 Opens mKATP and inhibits complex II: (A): mKATP activity was measured
by osmotic swelling as detailed inMaterials andmethods. LA-NO2, native linoleate (LA),
Glyb, and 5-HD were present at the indicated concentrations. *pb0.05 vs. ATP alone.
#pb0.05 vs. ATP plus LA-NO2. (B): Complex II activity in the presence of LA-NO2 was
determined as detailed inMaterials andmethods. Values are expressed as percentage of
control complex II rate (128±26 nmol DCPIP min−1mg protein−1).
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In addition to ROS, much recent interest has focused on mKATP as a
possible target for NO• or its redox congeners [20]. While NO• effects
on mKATP activity in intact cells are thought to be mediated via cGMP
signaling [52,53], direct effects of NO• on the puriﬁed channel have
been measured in planar bilayer studies [28]. In addition NO• was
shown to activate mKATP in mitochondria by using ﬂavoprotein
ﬂuorescence as a read-out [27]. However, the dose response of mKATP
to NO• in intact mitochondria is unknown. Fig. 3A and B shows that
S-nitrosoacetylpenacillamine (SNAP) dose-dependently activated
mKATP, in a glybenclamide and 5-HD sensitive manner. Notably,
N10 μM SNAP led to mKATP inhibition, presumably due to NO•
inhibition of cytochrome c oxidase [54] leading to mitochondrial de-
energization, removing the driving force for K+ uptake. SNAP did not
activate swelling in Na+ based buffers (supplemental Fig. 4). Notably,
the optimal SNAP concentration for mKATP channel opening in this
study (10 μM) is 3 orders of magnitude lower than previously
reported (Table 1). We are unsure as to the origin of this very large
discrepancy [20].
Therehasbeenmuch interest in thepossibility thatmitochondriamay
contain a nitric oxide synthase, termed “mtNOS”. Despite recent
developments including retraction of some work [55–57], NOS is a
common contaminant of isolated mitochondrial preparations [58]. This
may be particularly applicable to mKATP studies, since a rapid and crude
mitochondrial isolation is required toeffectivelymeasure channel activity
(full experimental details are in the online supplement) [32,36]. The data
in Fig. 3C show that the NOS substrate L-arginine stimulates mKATPopening, in a manner sensitive to the NOS inhibitor L-NAME. No effect
was seen with D-arginine, suggesting that the origin of this effect resides
at the level of a mitochondrially associated NOS or L-NAME-sensitive
enzyme. Unfortunately, further puriﬁcation of mitochondria that would
be required to assert a mitochondria-resident NOS in mediating these
effects, also results in loss of mKATP channel activity, in a manner
mechanistically related to classical channel “run-down” [38].3.5. Certain RNS can activate mKATP, via a mechanism involving
mitochondrial complex II
In addition to “classical”RNS such asNO•, RNS such as nitro-lipids and
nitroxyl may regulate mKATP. Nitro-lipids are an emerging class of anti-
inﬂammatory signaling lipids which can mediate NO• signaling, [59,60]
and are known to be generated during IPC [34,61]. One example of a
nitro-lipid, nitrolinoleate (LA-NO2), canelicit cardioprotection in a cGMP-
independent manner [34,62]. Fig. 4A shows that, low doses (0.5 μM) of
LA-NO2 opened the mKATP channel in a 5-HD- and glyburide-sensitive
manner, while native linoleic acid (LA) did not. Complex II of the
mitochondrial respiratory chain has been proposed as an important
regulator of mKATP activity [31,32,63], and in this regard Fig. 4B shows
that LA-NO2, but not LA, inhibited complex II in a dose-dependent
manner. Notably however, the amount of LA-NO2 required to open the
channel was signiﬁcantly lower than that required to inhibit complex II
(see below for discussion).
The disparate effects of LA-NO2 (stimulation mKATP activity), and
lipid hydroperoxide (no effect onmKATP, see section 3.1) highlight the
different chemical properties of these species. While both are
hydrophobic reactive lipids, only LA-NO2 possesses an electrophilic
moiety that can adduct thiols by Michael addition [61]. Thus it is
suggested that the mechanism of LA-NO2 mediated mKATP opening
may involve modiﬁcation of thiols on the channel (c.f. section 3.3).
The levels of LA-NO2 generated inside mitochondria during IPC
may reach 1 μM [34], raising the possibility that LA-NO2 is an
important endogenous mKATP regulator. However, we previously
showed that cardioprotection induced by exogenously added LA-NO2
was insensitive to mKATP blockers [34], suggesting that other
mechanisms of LA-NO2 action (e.g. mild uncoupling) may account
for its cardioprotective effects.
Similar to nitro-lipids, the importance of nitroxyl in cardiovascular
signaling has also been the subject of recent attention [29,37]. In
agreement with previous ﬁndings, we showed that the nitroxyl donor
Angeli's salt (AS) dose-dependently inhibited complex II in rat heart
mitochondria (Fig. 5A). Consistent with an interaction between
complex II and the mKATP channel, we also found that Angeli's salt
Fig. 5.Nitroxyl inhibits complex II, opensmKATP and is cardioprotective: (A): Complex II
activity was measured, following nitroxyl exposure of mitochondria, as described in
Materials and methods. Values are expressed as percentage of control complex II rate
(108±8 nmol DCPIP min−1mg protein−1). (B): Nitroxyl activation of mKATP was
monitored using a novel Tl+ ﬂux assay as described in Materials and methods. Data
show the magnitude of change in intra-mitochondrial Tl+ based ﬂuorescence following
Tl+ addition, relative to control. 5-HD, Glyb, the nitroxyl donor Angeli's salt (AS) and
decomposed AS (ASDC) were present at the indicated concentrations. *pb0.05 vs. ATP
alone. #pb0.05 vs. ATP plus 5 μM AS. (C): Nitroxyl protects against cardiomyocyte IR
injury. Cell viability was measured via Trypan blue exclusion at the end of
reoxygenation, as described in Materials and methods, and expressed as percentage
of control (normoxic) cell viability. 5-HD, Glyb, Angeli's salt (AS), decomposed AS
(ASDC), the PKG inhibitor KT-5823 (KT) or the soluble guanylate cyclase inhibitor ODQ
were present at the indicated concentrations. *pb0.05 vs. IR alone. #pb0.05 vs. IR plus
5 μM AS.
Fig. 6. Schematic showing redox regulation of mKATP. Nitroxyl (HNO), RSNO, and LA-
NO2 activate the channel, possibly via thiols on the channel itself or on complex II of the
respiratory chain. The ability of low molecular weight thiols (RSH) to inhibit the
channel may also bemediated via thiols on the channel or on complex II. In contrast, the
effects of NADPH are likely no mediated via thiols. The ability of NO• to activate the
channel may be mediated via the generation of secondary RNS (e.g. RSNO, LA-NO2,
HNO), which can activate the channel via PKG-independent mechanisms, or via
classical NO• protein kinase signaling. ROS (in particular H2O2) can also activate the
channel, via mechanisms that may include thiol modiﬁcation or protein kinase
signaling. The nature of the interaction between complex II and the subunits of the
mKATP channel itself remains to be elucidated.
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Furthermore, in agreement with previous studies [29,64] Angeli's salt
was protective in a cardiomyocyte model of IR injury. This protection
was sensitive to 5-HD and glyburide, but insensitive to the guanylate
cyclase inhibitor ODQ or the protein kinase G inhibitor KT-5823
(Fig. 5C). The role of other known components of the preconditioning
signaling pathway (e.g. PKC, ERK, PI3 kinase) in mediating the effects of
Angeli's salt is currently unknown, although none of these signals has
previously been linked to nitroxyl. Together, these data suggest that
Angeli's salt mediated cardioprotection proceeds via non-PKG mediat-
ed activation of mKATP, possibly involving an inhibition of complex II.
Both nitroxyl and LA-NO2 inhibit mitochondrial complex II,
activate mKATP, and are known to react with complex II thiols
[30,34]. This suggests that modiﬁcation of complex II thiols may
underlie the mechanism of mKATP activation. However, the concen-
trations of nitroxyl and LA-NO2 which activated mKATP did not
signiﬁcantly inhibit complex II enzymatic activity (Figs. 4 and 5). In
this regard, nitroxyl and LA-NO2 are similar to other species which
activate the mKATP at doses far below those at which they inhibit
complex II, including atpenin A5 [32], malonate [31] and diazoxide
[65]. Thus, the regulation of mKATP activity appears to be mechanis-
tically divorced from the bulk enzymatic activity of complex II itself.
The fact that 5 unrelated compounds which inhibit complex II by
distinct mechanisms all activate mKATP at lower concentrations,
collectively suggests that a small sub-population of complex II may
play an important role in regulating mKATP activity, while not
impacting total complex II enzymatic activity.4. Conclusions
In summary, a variety of redox active species, including ROS, RNS,
antioxidants, and reductants, all act on the mKATP. While a broad
conclusion of this work can be summarized as “oxidants activate,
reductants inhibit”, it is apparent that many species do not conform to
this simple model. Key examples include NADPH, which may regulate
the channel via direct binding, and LA-NO2 and nitroxyl, which are
thought to mediate their effects via complex II. A summary of the
potential mechanisms of mKATP channel modulation by various
species is shown in Fig. 6. Clearly, further work in this area, including
the molecular identiﬁcation of the mKATP itself, and the redox-
sensitive residues within it, will facilitate a better understanding of
the role that channel regulation by redox plays in events such as IPC.
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